Rebecca Taub Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rebecca Taub.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rebecca Taub. Rebecca Taub is SVP, Research & Development in VIA Pharmaceuticals, Inc. ($CAQ) and Chief Medical Officer, EVP R&D in SYNTA PHARMACEUTICALS CORP ($SNTA) and Pres., R&D, and CMO in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and President of R&D in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and See Remarks in MADRIGAL PHARMACEUTICALS, INC. ($SNTA).
Latest Insider Trading Transactions of Rebecca Taub
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | See Remarks | Option Exercise | A | 119.49 | 44,000 | 5,257,560 | 44,000 | |
| Mar 05 2020 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Pres., R&D, and CMO | Option Exercise | A | 91.79 | 44,000 | 4,038,760 | 44,000 | |
| Jul 11 2019 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | President of R&D | Option Exercise | A | 101.30 | 8,000 | 810,400 | 8,000 | |
| Mar 11 2019 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Chief Medical Offic ... | Option Exercise | A | 127.96 | 38,000 | 4,862,480 | 38,000 | |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Chief Medical Offic ... | Buy | S | 287.46 | 73,526 | 21,135,784 | 655,540 | 582 K to 655.5 K (+12.63 %) |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Chief Medical Offic ... | Buy | S | 287.46 | 73,526 | 21,135,784 | 655,540 | 582 K to 655.5 K (+12.63 %) |
| Mar 05 2018 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Chief Medical Offic ... | Option Exercise | A | 124.45 | 38,000 | 4,729,100 | 38,000 | |
| Mar 06 2017 | SNTA | MADRIGAL PHARMACEU ... | Taub Rebecca | Chief Medical Offic ... | Option Exercise | A | 15.80 | 37,300 | 589,340 | 37,300 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Option Exercise | A | 9.45 | 143,557 | 1,356,614 | 143,557 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 28,740 | 0 | 432,872 | 404.1 K to 432.9 K (+7.11 %) |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 404,132 | 0 | 404,132 | 0 to 404.1 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 729,066 | 0 | 729,066 | 0 to 729.1 K |
| Dec 19 2008 | CAQ | VIA Pharmaceutical ... | Taub Rebecca | SVP, Research & Dev ... | Grant | A | 0.00 | 125,000 | 0 | 157,500 | 32.5 K to 157.5 K (+384.62 %) |
| Dec 19 2008 | CAQ | VIA Pharmaceutical ... | Taub Rebecca | SVP, Research & Dev ... | Buy | P | 0.30 | 32,500 | 9,750 | 32,500 | 0 to 32.5 K |
| Jan 16 2008 | CAQ | VIA Pharmaceutical ... | Taub Rebecca | SVP, Research & Dev ... | Option Exercise | A | 2.90 | 235,000 | 681,500 | 235,000 |
Page: 1